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Abstract We identified a human homolog of Drosophila warts
tumor suppressor gene, termed h-warts, which was mapped at
chromosome 6q24-25.1. The h-warts protein has a serine/
threonine kinase domain and is localized to centrosomes in
interphase cells. However, it becomes localized to the mitotic
apparatus, including spindle pole bodies, mitotic spindle, and
midbody, in a highly dynamic manner during mitosis. Further-
more, h-warts is specifically phosphorylated in cells at mitotic
phase, most likely by Cdc2 kinase. These findings suggest that h-
warts functions as a component of the mitotic apparatus and is
involved in proper progression of mitosis.
z 1999 Federation of European Biochemical Societies.
Key words: Centrosome; Mitotic spindle; Cdc2; Midbody;
Nocodazole; Chromosome 6q
1. Introduction
Mitosis is characterized by dramatic morphological changes
which occur in a strictly sequential order, including cytoskel-
etal disassembly, breakdown of the nuclear envelope, chro-
mosome condensation, segregation and, ¢nally, daughter cell
separation. Multiple lines of evidence suggest that the molec-
ular mechanisms of such events during mitosis are driven by
two fundamental chemical reactions, phosphorylation and
degradation of diverse proteins [1]. Identi¢cation of the ki-
nases involved and determination of how they are coordinated
are required for understanding how mitosis is regulated.
Recent studies have demonstrated that several serine/threo-
nine kinases, which are highly conserved in amino acid se-
quence from yeast to human, are located on the mitotic ap-
paratus during mitosis. These include yeast Cdc5p/Drosophila
polo/human Plk1 [2^4], yeast Ipl1/Drosophila aurora/human
Aik/human Aim [5^8], and Aspergillus nidulans NIMA/human
Neks [9,10]. Drosophila and yeast mutants of these kinase
genes exhibit abnormal regulation of mitosis, such as mono-
polar spindle, unequally separated bipolar spindle and cytoki-
nesis failure. Therefore, identi¢cation of mammalian homo-
logs of the mitosis-related kinases could provide a clue to
the mechanisms regulating normal spindle assembly and chro-
mosomal segregation in mammalian cells.
The warts (also referred to as lats) gene was identi¢ed based
on its ability to act as a tumor suppressor in Drosophila [11].
Deletion of this gene leads to the formation of cell clones that
are rounded and greatly overgrown, and literally generate
‘warts’ on their legs and body. Thus, the warts gene is con-
sidered to be important in controlling cellular morphogenesis
and proliferation. The protein encoded by the warts gene has
a serine/threonine kinase domain which is highly homologous
to the human myotonic dystrophy protein kinase (DM-PK)
[12], the mammalian Rho-associated kinases [13] and yeast
Dbf2 and Dbf20 kinases [14]. Many of the DM-PK family
kinases have been reported to be involved in progression of
the cell cycle, especially in mitosis. In the budding yeast Sac-
charomyces cerevisiae, temperature-sensitive mutants of Dbf2
arrest in telophase with a terminal ‘dumbbell’ phenotype in
which they display an elongated spindle and divided chroma-
tin. The kinase activity of Dbf2 protein is cell cycle regulated
with a peak in late mitosis, suggesting that Dbf2 is considered
to play a role in late mitotic events [15].
In this paper we report the isolation of a putative human
protein kinase, termed h-warts, which is highly related to the
Drosophila warts protein and describes its possible involve-
ment in cell cycle regulation. Immunolocalization experiments
show that the h-warts protein is found at centrosome in in-
terphase cells while it becomes localized to the mitotic appa-
ratus in a highly dynamic manner during mitosis. Further-
more, although expression levels of h-warts protein are
constant and do not £uctuate throughout the cell cycle, h-
warts is phosphorylated in the mitotic phase and hyperphos-
phorylated when the cell cycle is arrested by disruption of the
spindle with nocodazole. Thus, these results suggest that h-
warts functions as a component of the mitotic apparatus and
is modulated during mitosis.
2. Materials and methods
2.1. EST database screening and PCR-based full-length cDNA cloning
We searched for human homologs of the Drosophila warts gene by
scanning a database of human genes identi¢ed by the expressed se-
quence tag (EST) method using tblastn. The EST clone with the
accession number Z13665 has a signi¢cant sequence similarity. Based
on the sequence information of the Z13665 clone, we performed PCR-
based full-length cDNA cloning, as described previously [16,17]. For
ampli¢cation of the 5P region, the ¢rst PCR was performed using only
P1 primer (5P-CTTGTTTTTCCTAACAGTAATAGG-3P) to amplify
single-strand cDNA from a human fetal brain cDNA library (Clon-
tech, Marathon-Ready cDNA) in a 15 Wl reaction volume for
50 cycles. The ¢rst PCR product was used as a template in the second
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run, where P2 (5P-TGAAGTTGTAATCTGTTTCTTTTC-3P) and
AP2 (5P-ACTCACTATAGGGCTCGAGCGGC-3P) were utilized as
primers to amplify the 5P region of cDNA. For the 3P region ampli-
¢cation, P6 (5P-TATTCTCCTCAAGCATTTAAATTC-3P) was used
for the ¢rst PCR, and P7 (5P-TTTATGGAGCAACATGTAGA-
AAAT-3P) and AP2 were used for the second PCR. The PCR frag-
ments were ligated into a pCR2 TA cloning vector and sequenced.
2.2. Radiation hybrid mapping of h-warts gene
PCR was performed to detect h-warts sequences in the Genebridge
4 Radiation Hybrid Screening Panel (Research Genetics, Inc.) using a
set of primers (S-1: 5P-ACACAGGCTCAGAGATTAAAA-3P and
AS-1: 5P-CCTCGAATTCCAGGCCCTTTTACAA-3P) which were
designed based on a partial genomic sequence of the h-warts gene.
The S-1 and AS-1 primers were expected to amplify a 97-bp PCR
product from human genomic DNA as a template. PCR was carried
out as previously described [16]. The PCR results of the Radiation
Hybrid Panel were sent to the Whitehead Institute/MIT Center for
Genome Research via WWW (http://www-genome.wi.mit.edu/) for
mapping of the genes relative to the radiation hybrid map of the
human genome.
2.3. Northern blot analysis
Northern blot derived from multiple human tissues containing 2 Wg
of poly(A) RNA per lane were obtained from Clontech. The mem-
branes were hybridized with an 1178-bp cDNA fragment of h-warts
that had been labeled with [K-32P]dCTP by random primed labeling
method. The membranes were exposed to X-ray ¢lm with an intensi-
fying screen for 3 days at 370‡C.
2.4. Expression of GST fusion proteins
The cDNA fragments coding three deletion mutants of h-warts, WP
(amino acid nos. 136^403), WN (nos. 395^700) and WK (nos. 682^
1130), were ampli¢ed by PCR using the following sets of primers:
WP, 5P-CAATTGAATTCATTAGTAAAATG-3P and 5P-CTGAG-
GAATTCTTCCATTTGTAT-3P ; WN, 5P-CAGGGGAATTCGCTG-
CTCCTTCGTCATATAC-3P and 5P-CAAACATAGAATTCTCCAT-
TTTAGCCCTTTTA-3P ; WK, 5P-CAGGATGAATTCAGAAAGAT-
GCTTTGCC-3P and 5P-CATTTAGAATTCAGTGTGTTAAAC-3P,
and subcloned into a pGEX-2TH bacterial expression vector. The
expression and puri¢cation of the GST fusion proteins were described
previously [16].
2.5. Production of anti-h-warts polyclonal antibodies and Western blot
analysis
Two polyclonal antibodies against h-warts protein, termed C-2 and
G-3, were raised by subcutaneous immunization of rabbit and rat
with a synthetic peptide (KSAKHIKEKEQRDPIYLRDKVTQRH)
and the bacterially expressed GST-WP protein, respectively.
For the Western blot analysis, samples containing equal amounts of
protein (20 Wg) from lysates of cultured cells were separated on a 6%
polyacrylamide gel and transferred to a nitrocellulose ¢lter with a
constant current of 180 mAî for 2 h. The ¢lters were probed with
the C-2 antibody or G-3 using the method previously described
[16].
2.6. Construction of the h-warts expression plasmid
The full-length ORF of the h-warts cDNA was ampli¢ed by PCR
from the Marathon-Ready cDNA (Clontech) by a set of primers, wts-
sense (5P-GATTCTAGAATGAAGAGGAGTGAAAAGCCAG-3P)
and wts-antisense (5P-CCTTCTAGAAATCCTCATTACATT-3P) con-
taining XbaI site (underlines). The PCR fragments were digested with
XbaI, and ligated into pCGN expression vector. The nucleotide se-
quence of the insert was con¢rmed. To express HA-tagged h-warts,
the pCGN-h-warts was transfected into COS7 cells by the liposome-
mediated gene transfer method.
2.7. Immuno£uorescence staining and confocal laser scanning
microscopic analysis
U2OS cells seeded on Labtek chamber slides (Nunc) were pre-
treated with a microtubule stabilizing bu¡er (80 mM potassium
PIPES, pH 6.8, 5 mM EGTA, 1 mM MgCl2) containing 0.5% Triton
X-100 and then ¢xed with methanol for 10 min at 320‡C [8,18]. Fixed
cells were washed with a solution of 0.1 M PIPES, pH 7.2, 1 mM
MgSO4, 1 mM EGTA, 1.83% L-lysine, 1% BSA and 0.1% sodium
azide and were subsequently incubated for 1 h with anti-h-warts
(G-3), anti-K-tubulin and anti-Q-tubulin antibodies (Sigma). This was
followed by incubation with FITC-conjugated and Cy3-conjugated
secondary antibodies (Biosource). DNA was stained by adding propi-
dium iodide (Sigma) to a ¢nal concentration of 1 Wg/ml. After being
washed with PBS, samples were mounted in 50% glycerol and visual-
ized with a confocal laser microscope (Fluoview, Olympus).
2.8. Double thymidine cell cycle synchronization at G1/S phase
HeLa cells were treated with 1 mM thymidine for 24 h, followed by
a 8 h release in fresh Dulbecco’s modi¢ed Eagle’s minimum essential
medium (D-MEM) with 5% fetal calf serum and successive retreat-
ment with thymidine for 14 h, and released to enter the cell cycle [19].
2.9. Alkaline phosphatase treatment
Nocodazole-treated HeLa cell lysate was extracted with digestion
bu¡er (100 mM Tris [pH 8.0], 40 mM NaCl, 1 mM MgCl2, and 0.1%
SDS), followed by centrifugation at 12 000Ug for 15 min. The lysate
was treated with 30 U of alkaline phosphatase (TAKARA) for 2 h at
37‡C in the presence or absence of phosphatase inhibitors (2.5 mM
Na3VO4, 50 mM NaF, 100 mM L-glycerophosphate and 2.5 mM
EDTA) and then immunoblotted with C-2 antibody.
2.10. In vitro kinase assay
HeLa cells were lysed with IP bu¡er (20 mM Tris [pH 8.0], 150 mM
NaCl, 1% NP-40, 10% glycerol, 5 mM EDTA, 0.5 mM EGTA, 20 mM
L-glycerophosphate, 50 mM NaF, 0.5 mM ABSF, 1 WM leupeptin,
1 mM Na3VO4 and 1 WM microcystin LR) for 20 min. Lysates were
centrifuged at 14 000Ug for 20 min, and the supernatant was used for
the kinase assay. The kinase assays were conducted at 25‡C for 30 min
in a ¢nal volume of 50 Wl containing 20 mM Tris (pH 7.4), 10 mM
MgCl2, 10 WCi of [Q-32P]ATP (3000 Cu/mmol), 1 WM microcystin, 8 Wg
of cell lysates, and 10 Wg of GST-h-warts. To terminate the reaction
and separate the phosphorylated GST fusion proteins, each reaction
mixture was immediately chilled and mixed with 50 Wl of GSH-agar-
ose beads and 0.5 ml of ice-cold TNE bu¡er containing 20 mM Tris
[pH 7.4], 100 mM NaCl, 1% NP-40, 1 mM EDTA, 10 mM L-gly-
cerophosphate, and 1 mM Na3VO4, followed by rocking for 30 min at
4‡C. The GSH-agarose beads were then washed three times with TNE
bu¡er, and boiled in 30 Wl of Laemmli sample bu¡er to elute GST
fusion proteins. The samples were separated on 8% SDS-PAGE and
visualized by autoradiography.
3. Results
3.1. Identi¢cation of the human gene homologous to Drosophila
warts
To identify the human homolog of the Drosophila warts (d-
warts), we performed sequence database searching using the
Blast algorithm. A tblastn search of the GenBank database
using the non-catalytic domain of Drosophila warts peptide
sequences revealed that one EST clone, with the accession
number Z13665, has high sequence similarity, and it was
not found to be identical to any previously identi¢ed genes.
Based on the sequence of Z13665, we performed a two-step
PCR to clone the full-length cDNA. We identi¢ed a 3390-bp
cDNA which contains a single large open reading frame en-
coding a polypeptide of 1130 amino acids (GenBank accession
no. AF164041). We refer to this gene as h-warts (human
warts). The deduced amino acid sequences of h-warts aligned
with the Drosophila warts are shown in Fig. 1. The h-warts
protein has a putative kinase domain in the C-terminal por-
tion and contains all of the 12 protein kinase catalytic sub-
domains characteristic of a serine/threonine kinase [20]. The
GXGXXG ATP binding consensus motif characteristic of
many protein kinases is found in subdomain 1. An invariant
lysine at position 734 of the protein, necessary for the ATP
binding, is also present. Inspection of the h-warts amino acid
sequence revealed that it contains several conserved clusters of
basic amino acids (607^623, 682^698, 659^662 and 723^739)
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and six proline rich sequences (236^237, 247^251, 256^258,
263^266, 301^304 and 372^375).
A Blastp search of the non-redundant protein database re-
vealed that the overall structure of the h-warts protein shows
the highest similarity to that of d-warts. Particularly, the ki-
nase domain of h-warts has 76% identity to that of the
d-warts protein [11], 35% to the DM-PK protein [12], 46%
to the PK428 protein [21], and 37% to the S. cerevisiae
Dbf2 protein [14]. During preparation of this manuscript, a
human kinase, LATS1 [22], which has high homology to
d-warts has been reported. We believe that h-warts and
LATS1 genes are identical.
To identify the chromosomal localization of the h-warts
gene, we performed PCR mapping using somatic cell hybrid
analysis. PCR products expected to be 97 bp in size were
ampli¢ed using A1 and A2 primers from 20 of 93 hybrid
cell lines in the Genebridge 4 radiation hybrid panel. Linkage
analysis based on comparison with the human chromosomal
constructs of all hybrids, as determined by the manufacturer
and the Whitehead Institute/MIT Center for Genome Re-
search, localized the h-warts gene to chromosome 6q24-25.1
and placed it 3.05 cR from D6S311 (Fig. 2a).
To examine the tissue expression of h-warts mRNA, North-
ern blot analysis of di¡erent human tissues was performed
(Fig. 2b). A 9-kb mRNA was detected in most of the human
adult tissues except for lung and kidney.
3.2. Detection of the h-warts protein
To verify the expression of h-warts protein in cultured cells,
two polyclonal antibodies, termed C-2 and G-3, were gener-
ated against a synthetic peptide derived from a C-terminal
region of h-warts proteins and a bacterially expressed GST
protein fused with N-terminal portion of h-warts protein
(WP), respectively. Western blot analysis revealed that C-2
and G-3 antibodies detected a band of about 165 kDa in
lysates from COS7 cells transfected with the HA-tagged h-
warts plasmid and HeLa cells (Fig. 2c). These results indicate
that C-2 and G-3 antibodies recognize both the endogenous
and the ectopically expressed h-warts.
3.3. Subcellular localization of h-warts during cell cycle
To examine the subcellular localization of endogenous h-
warts, U2OS cells were immunocytochemically stained with
the G-3 antibody. In various stages of the cell cycle, h-warts
varied its localization. In interphase cells, G-3 antibody de-
tected one or two closely spaced dots which were located close
Fig. 1. Comparison of sequence identities in human (h-warts) and Drosophila warts (d-warts) protein. The protein sequences were compared by
Multiple Sequence Alignments at BCM Search Launcher (http://dot.imgen.bcm.tmc.edu:9331/multi-align/multi-align.html). Amino acid residues
on h-warts identical to d-warts protein in the same position are indicated by shading. The putative protein kinase catalytic domain (DM-PK
domain) is indicated by underline. The GXGXXG ATP binding consensus motif and an invariant lysine residue are indicated by asterisks and
an open diamond, respectively. Proline rich sequences are boxed.
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to the nuclear envelope (Fig. 3a). These G-3 positive dots lay
at the center of the interphase microtubule array (Fig. 3b, c)
and were also co-stained with anti-Q-tubulin antibody (Fig. 3d,
e, f), suggesting that they represent centrosomes. In prophase,
it localized with spindle pole bodies and then with the entire
mitotic spindle through metaphase into the early stage of
anaphase (Fig. 3g, h, i). In mid-anaphase, the h-warts trans-
located toward the anaphase spindle midzone (Fig. 3j, k, l).
As the cells progress into telophase, h-warts became concen-
trated to the midbody that connects daughter cells (Fig. 3m,
n, o). These dynamics of h-warts protein during mitosis sug-
gests that h-warts plays a role in the mitotic machinery during
cell cycle progression.
3.4. Phosphorylation of h-warts in the mitotic checkpoint
The Drosophila warts gene is known to be required for the
control of cell proliferation. Furthermore, h-warts has a sig-
ni¢cant homology with budding yeast cell cycle regulated ki-
nases, DBF2 and DBF20. This evidence, together with our
immunolocalization study, evoked our great interest to exam-
ine the modulation of h-warts at the di¡erent stages of the cell
cycle. We ¢rst asked whether h-warts protein level is altered
during the cell cycle. HeLa cells were synchronized at the G1/
S boundary by a double thymidine block method. At di¡erent
times after release from the block, cells were harvested and
analyzed for h-warts expression by Western blotting with C-2
antibody. Total expression levels of h-warts did not change
signi¢cantly throughout the cell cycle. However, a slower mo-
bility of the h-warts band was observed in cells at 7^9 h after
release from G1/S boundary, where most of the cells were in
mitosis (Fig. 4a, lanes 4^6). The band shift became more
obvious when cells were arrested at mitosis with nocodazole
treatment (Fig. 4a, lane 9). Furthermore, in the early G1 cells,
which were obtained by plating the mitotic arrested cells in
nocodazole-free media for another 5 h, the lower band be-
came predominant while the upper band was disappeared
(Fig. 4a, lane 10). To examine the nature of the electropho-
retic band shift of h-warts, the nocodazole-treated HeLa cell
lysates were incubated with alkaline phosphatase. Alkaline
phosphatase eliminated the gel shift of h-warts seen in noco-
dazole-treated cells, and the phosphatase-mediated conversion
was inhibited by phosphatase inhibitors (Fig. 4b). These ¢nd-
ings indicate that h-warts is speci¢cally phosphorylated in
cells at mitosis and in the cells arrested at the mitotic check-
point by nocodazole treatment.
To determine whether the nocodazole-induced phosphoryl-
ation of h-warts occurred as a result of a spindle assembly
defect or non-speci¢cally irrespective of the cell cycle, we
treated HeLa cells in various phases of the cell cycle with
nocodazole and analyzed their electrophoretic mobility. Cells
were synchronized at the G1/S boundary by double thymidine
block and then induced to enter the cell cycle. Electrophoretic
band shift caused by nocodazole treatment for 4 h was specif-
ically observed in mitotic cells (Fig. 4c, lane 4), whereas the
mobility of h-warts was not a¡ected when cells were in the
G1, S or G2 phase (Fig. 4c, lanes 1, 2, 3, 5). Thus, phospho-
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Fig. 2. Characterization of h-warts. a: Radiation hybrid mapping of
the h-warts gene. The h-warts gene was mapped at 3.05 cR from
D6S311 on chromosome 6q24-25.1. b: Expression of the h-warts
transcript in various human tissues. The blots were hybridized with
a speci¢c cDNA probe of h-warts. The size marker (kb) is indicated.
c: Western blot analysis of h-warts. Lysates prepared from COS7
cells transfected with the HA-tagged h-warts plasmid (pCGN-h-
warts) (lanes 2, 4) and with pCGN (lanes 1, 3) were detected by C2
(lanes 1, 2) and G3 (lanes 3, 4) anti-h-warts antibodies. Lysates pre-
pared from HeLa cells were also detected by C2 (lane 5) and G3
(lane 6) anti-h-warts antibodies.
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rylation of h-warts is closely related to disruption of mitotic
spindle microtubule, which is accompanied by spindle assem-
bly checkpoint activation.
For an alternative approach to show the speci¢c phospho-
rylation of h-warts during mitosis, we performed an in vitro
kinase assay using cell extracts as sources of the enzyme and
three GST-h-warts deletion mutants (WP, WN and WK) as
substrates. Among these deletion mutants, only WN was sig-
ni¢cantly phosphorylated by both mitotic lysates and noco-
dazole treated lysates (data not shown).
Among the protein kinases that have been implicated in the
control of mitotic events, the role of Cdc2/cyclin B complex is
pivotal and has been well characterized [23]. To examine the
involvement of Cdc2/cyclin B complex in the phosphorylation
of h-warts, we performed an in vitro kinase reaction of the
WN domain using a mitotic lysate from which Cdc2/cyclin B
Fig. 3. Subcellular localization of h-warts in U2OS cells during the cell cycle. The cells at various stages of the cell cycle (a^f, interphase; g^i,
metaphase; j^l, anaphase; m^o, telophase) were immunostained with anti-h-warts polyclonal antibody G3 visualized by FITC-conjugated
secondary antibody (green) and anti-K-tubulin antibody (c, k, n) or anti-Q-tubulin antibody (e) visualized by Cy3-conjugated secondary antibody
(red). DNA was stained with PI (a, h). The merged images are shown in a, c, f, i, l and o.
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was removed by p13suc1 beads. We found that phosphoryla-
tion of GST-WN was signi¢cantly abolished by depleting
Cdc2 from mitotic lysate (Fig. 4d). These data suggest that
Cdc2 or Cdc2-associated kinase(s) is responsible for the mi-
totic-speci¢c phosphorylation of h-warts in vitro.
4. Discussion
In this study we have identi¢ed and characterized a human
homolog of the Drosophila warts tumor suppressor, desig-
nated h-warts. The h-warts protein has signi¢cant homology
to DM-PK family proteins. Protein kinases belonging to the
DM-PK family are not only structurally, but also function-
ally, related to each other by an interesting coincidence. The
budding yeast Dbf2 has been shown to genetically interact
with Bub2p, one of the checkpoint components localizing to
spindle pole bodies, and, when mutated, blocks exit from
mitosis, resulting in formation of the ‘dumbbell’ phenotype
[15,24]. The ¢ssion yeast Orb6 is reportedly required for main-
tenance of cell polarity during interphase and acts as an in-
hibitor of mitosis, suggesting that Orb6 takes part in a path-
way to coordinate cell morphogenesis with progression
through the cell cycle [25]. Rho-associated kinase (Rho-ki-
nase) was shown to phosphorylate a type III intermediate
¢lament protein exclusively at the cleavage furrow during
cytokinesis, and the expression of the dominant-negative
form inhibited the cytokinesis of Xenopus embryo and mam-
malian cells [26]. Citron kinase, another Rho target protein,
also localizes to the cleavage furrow and midbody, and over-
expression of citron mutants abrogates cytokinesis [27]. These
lines of evidence indicate that many DM-PK family kinases
are found in the mitotic apparatus and play an important role
in progression of mitosis.
Immunocytochemical studies show that subcellular localiza-
tion of h-warts alters during the cell cycle in a highly dynamic
manner. During interphase, h-warts localizes to the centro-
some. However, it becomes associated with the mitotic spindle
during mid-mitosis and concentrated at the midbody in telo-
phase. The dynamic localization of h-warts on the mitotic
apparatus leads to our proposal that h-warts take a signi¢cant
part in the cell cycle machinery. This hypothesis is supported
by two biochemical characteristics of h-warts protein. First, h-
warts is phosphorylated at the mitotic phase and hyperphos-
phorylated when the mitotic checkpoint is activated by noco-
dazole treatment. Second, the non-catalytic portion (WN re-
gion) of the protein is speci¢cally phosphorylated by a kinase
present in the mitotic cell lysate, which is most likely to be
Cdc2/cyclin B complex. Cdc2 is known to phosphorylate a
number of proteins, including nuclear lamins, nucleolin, cy-
toskeletal proteins, Src family protein kinases, kinesin-like
motor protein HsEg5, and spindle-associated protein PRC1
[1]. The phosphorylation of these proteins is believed to alter
their functions to trigger various events of mitosis [1]. Taken
Fig. 4. Mitosis-speci¢c phosphorylation of h-warts. a: Post-transla-
tional modi¢cation of h-warts during cell cycle. HeLa cells were
synchronized at the G1/S boundary by double thymidine block. Fol-
lowing release from G1/S, cells were harvested at the various time
points indicated (lanes 1^8). To block cells at mitosis, nocodazole
(50 ng/ml) was added into cells at 5 h after release from G1/S and
incubated for another 7 h (Noc: lane 9). After removal of nocoda-
zole, cells were incubated in nocodazole-free media for another 5 h
to obtain interphase cell (NR: lane 10). Samples were analyzed for
h-warts protein by immunoblotting. b: Phosphatase treatment of
cell extracts. Interphase (lane 1) or nocodazole-treated (lane 2)
HeLa cell extract (50 Wg) was immunoblotted with the C2 antibody.
The nocodazole-treated extract was incubated with 100 units of calf
intestinal alkaline phosphatase (CIAP) in the absence (lane 3) or
presence (lane 4) of phosphatase inhibitors at 37‡C for 30 min and
subjected to the immunoblot analysis with the C2 antibody. Arrow
and arrowhead indicate non-phosphorylated and phosphorylated
form of h-warts, respectively. c: The nocodazole-induced phospho-
rylation of h-warts occurred as a result of a spindle assembly defect.
HeLa cells were synchronized at the G1/S boundary and released
into the cell cycle. The cells were then exposed to nocodazole at 0 h
(lane 2, most of the cells were in G1/S phase), 4 h (lane 3, G2
phase), 8 h (lane 4, M phase) and 12 h (lane 5, G1 phase) to 4 h.
The cell lysates were immunoblotted with the C2 antibody. Control
lysate was obtained from the cells synchronized at the G1/S bound-
ary without nocodazole treatment (lane 1). Arrow and arrowhead
indicate non-phosphorylated and phosphorylated form of h-warts,
respectively. d: E¡ect of Cdc2 depletion on in vitro phosphorylation
of h-warts by mitotic lysate. GST-WN was incubated in the pres-
ence of [Q-32P]ATP with either bu¡er alone (lane 1), mock-depleted
mitotic cytosol (lane 2), or Cdc2-depleted mitotic cytosol (lane 3)
for 30 min at 25‡C. GST-WN was analyzed by SDS-PAGE and
autoradiography. Phosphorylated GST-WN is indicated by asterisk.
6
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together, it can be speculated that h-warts plays an important
role in the control of mitotic events on the mitotic apparatus,
which are functionally regulated by its phosphorylation state.
PCR mapping, using the radiation somatic cell hybrid pan-
el, localized the h-warts gene to chromosome 6q, 3.05 cR
apart from D6S311. The marker D6S311 was mapped at chro-
mosome 6q24-25.1, which has been reported to be the fre-
quent loss of heterozygosity region in human ovarian cancers
and cervical cancers [28,29]. Furthermore, transfer of chromo-
some 6q fragments, which contains D6S311, was shown to
suppress the tumorigenic phenotype of human breast cancer
and ovarian cancer cell lines [30,31]. These ¢ndings suggest
that the h-warts gene is one of the candidate tumor suppressor
genes in chromosome 6q24-25. Experiments to investigate
whether the h-warts gene is inactivated in human tumor cells
are in progress.
Mutagenesis screens and the identi¢cation of spontaneously
occurring mutations in Drosophila have led to the identi¢ca-
tion of over 50 genes in which mutations give an overgrowth
phenotype, and are therefore considered tumor suppressor
genes [32]. Recently, human homologs of these Drosophila
tumor suppressor genes have been identi¢ed and shown to
be implicated in various important cellular events, including
growth regulation, di¡erentiation and transformation [16,17].
Homozygous loss of Drosophila warts in somatic clones results
in cell-autonomous formation of epithelial tumors. Thus, the
Drosophila warts gene product is important for controlling
cellular morphogenesis, as well as proliferation [11]. Recently,
Tao et al. has reported a human kinase, LATS1, which has
high homology to Drosophila warts/lats [22] and appears to be
identical to h-warts. Analogous to its mutant in Drosophila,
mice de¢cient of LATS1 gene have been shown to develop
soft tissue sarcomas and ovarian stromal cell tumors [33].
Failure in regulation of mitosis is well-recognized as con-
tributing to chromosomal instability, which is a hallmark of
cancers. Our present ¢ndings, together with the evidence for
warts/LATS as a tumor suppressor in both Drosophila and
mouse, suggest that h-warts is an important element for prop-
er progression of mitosis, and that its loss of function leads to
chromosomal instability, a condition that facilitates cellular
transformation.
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